copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Rules | The Nasdaq Stock Market (b) Securities qualified for listing under this IM-5505-1 must begin trading on Nasdaq following the initial pricing through the mechanism outlined in Rule 4120 (c) (8) and Rule 4753
Public Company Alert 11. 21 - honigman. com If the disclosed amount of stockholders’ equity is less than $2 5 million and the company also fails to meet the Nasdaq Listing Rule 5550(b)’s market value standard and net income standard, then Nasdaq will deliver a notice of deficiency to the company
Agile Therapeutics Regains Compliance With Nasdaq Minimum Nasdaq Listing Rule 5550 (b) (1) requires companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,5000,000 (the “Stockholders’ Equity Requirement”)
Allarity Therapeutics Receives Extension from Nasdaq Hearings . . . To ensure compliance with the rules of The Nasdaq Capital Market (“Nasdaq”) by April 24, 2024, or sooner, the Company is working towards achieving a stockholders’ equity of at least $2 5 million and a minimum bid price of $1 00 per share or more for a minimum of 10 consecutive business days